Erin Wright
Stock Analyst at Morgan Stanley
(1.45)
# 1565
Out of 5,333 analysts
279
Total ratings
61.35%
Success rate
1.56%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PAHC Phibro Animal Health | Maintains: Equal-Weight | 20 21 | 22.5 | -6.67% | 21 | May 8, 2025 | |
IDXX IDEXX Laboratories | Maintains: Overweight | 548 558 | 491.88 | 13.44% | 13 | May 5, 2025 | |
CI Cigna Group | Maintains: Overweight | 379 390 | 333.22 | 17.04% | 5 | May 5, 2025 | |
CAH Cardinal Health | Maintains: Overweight | 142 166 | 148.27 | 11.96% | 10 | May 5, 2025 | |
PETS PetMed Express | Maintains: Underweight | 4 4 | 3.62 | -11.6% | 12 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 642 745 | 692.63 | 7.56% | 6 | Apr 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 19 | 17.61 | 7.89% | 8 | Mar 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 13 | 11.96 | 8.7% | 11 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 243 238 | 159.31 | 49.39% | 7 | Feb 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 301 285 | 249.47 | 14.24% | 3 | Feb 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 280 272 | 181.81 | 49.61% | 21 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 27 32 | n/a | n/a | 7 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 23 | 15.82 | 45.39% | 12 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 643 551 | 404.41 | 36.25% | 2 | Oct 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 9 7 | 11.23 | -37.67% | 7 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 69 65 | 68.67 | -5.34% | 4 | Nov 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 1000 920 | n/a | n/a | 6 | Nov 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 110 100 | 66.93 | 49.41% | 4 | Nov 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 587 587 | 380.46 | 54.29% | 3 | Jul 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 58 | n/a | n/a | 5 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 300 | 245.77 | 22.07% | 4 | Aug 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 142 | 176.99 | -19.77% | 4 | Aug 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 1 | n/a | n/a | 5 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 19 21 | n/a | n/a | 6 | May 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 39 42 | 12.04 | 248.84% | 5 | Jul 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 282 288 | 189.4 | 52.06% | 6 | Jun 18, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 14 | n/a | n/a | 2 | Jun 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 342 352 | 138.82 | 153.57% | 4 | May 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 44 | 1.99 | 2111.06% | 2 | May 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 159 169 | n/a | n/a | 6 | Apr 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 178 181 | 296.26 | -38.91% | 8 | Mar 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 17 | 81.85 | -79.23% | 6 | Feb 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 21 | n/a | n/a | 1 | Feb 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 104 121 | 39.63 | 205.32% | 7 | Jan 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 556 580 | 402.27 | 44.18% | 4 | Jan 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 11.98 | 192.15% | 1 | Jan 5, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 181 205 | 133.98 | 53.01% | 2 | Jul 23, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 30 | n/a | n/a | 1 | May 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 11 | 19.67 | -44.08% | 6 | May 5, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 175 157 | 148.88 | 5.45% | 1 | Apr 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 72 62 | n/a | n/a | 2 | Apr 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 34 30 | n/a | n/a | 4 | Feb 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 5 | n/a | n/a | 3 | Nov 18, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Apr 30, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 90 97 | n/a | n/a | 3 | Sep 18, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 38 | 23.07 | 64.72% | 1 | May 9, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 31 17 | 7.01 | 142.51% | 1 | Nov 20, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 300 308 | 473.33 | -34.93% | 1 | Oct 25, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 71 | n/a | n/a | 1 | Aug 7, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Aug 4, 2017 |